ISO EV Expands Globally from Body Composition Analyzers to AI 3D Skin Analyzers

Healthcare company strengthens its distribution network with EVE MUSE and EVE YOUNG

SEOUL, South Korea, Nov. 10, 2026 /PRNewswire/ — ISO EV, established in 2020, is expanding from body composition analyzers to AI-powered 3D skin analyzers. After entering the United States and Australia, the company exports to Canada, Japan, Taiwan region, Thailand, India, Southeast Asia, Europe, the Middle East, and South America.

Blue Planet Strengthens Singapore-India Partnership with Uttar Pradesh Waste Infrastructure Agreement

November 10, 2026

Telecom Review Group Accelerates the Journey to 10Giga GCC with U6GHz

November 10, 2026

ISO EV began exporting in 2021 and recorded $2.53 million in exports in 2022, earning a $1 Million Export Tower award. It won the $3 Million Export Tower for $4.70 million in exports in 2023 and the $5 Million Export Tower for $5.09 million in 2024. Exports reached $7.23 million last year, up 42% year on year.

Since 2023, it has expanded distribution partnerships and strengthened cooperation with EVOLT’s Australian headquarters and U.S. corporation, while securing master-franchise partners in Japan, the Philippines, Vietnam, Taiwan region, the UAE, Saudi Arabia, and the United Kingdom.

ISO EV is developing EVE MUSE, an AI 3D skin analyzer produced with Singapore-based EveLab Insight. The device uses five cameras to capture the face, analyze skin conditions, and create three-dimensional images. It supports consultations, treatment planning, and follow-up care at dermatology clinics, plastic-surgery clinics, and aesthetic institutions. The company is upgrading facilities for stable supply.

As of 2026, EVE MUSE had surpassed 1,000 units supplied in Korea about 18 months after market entry. The company is expanding its supply network through ID Plastic Surgery, DA Plastic Surgery, and DERNA, as well as partners in Europe and Asia.

In September, ISO EV launched EVE YOUNG. While EVE MUSE targets precision skin analysis at medical institutions and aesthetic clinics, EVE YOUNG is designed for cosmetics retailers, pharmacies, spas, and aesthetic salons. ISO EV aims to lead beauty-tech and medical-aesthetics markets by addressing demand for precise analysis and personalized care.

The company is pursuing expansion in Japan through an exclusive supply agreement under discussion with Tokyo-based C-Lab Co., Ltd., led by CEO Cho In-kyung. ISO EV aims to establish a broader global distribution network, including the United States, by the end of 2026.

EVE YOUNG will be introduced to buyers at COSMOPROF Hong Kong, from November 11 to 13. ISO EV plans to find distribution partners and expand internationally.